Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2018

Sep 10, 2018

29841_dirs_2018-09-10_71531723-8ef3-464d-a68f-f326d36d80f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-08-29

Reporting Person: Liddicoat John R (EVP & President of Americas)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 38768 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $78.00 2025-08-03 Ordinary Shares (17095) Direct
Stock Option (Right to Buy) $78.00 2025-08-03 Ordinary Shares (1283) Direct
Stock Option (Right to Buy) $88.06 2026-08-01 Ordinary Shares (15142) Direct
Stock Option (Right to Buy) $88.06 2026-08-01 Ordinary Shares (1136) Direct
Stock Option (Right to Buy) $83.97 2027-07-31 Ordinary Shares (27788) Direct
Stock Option (Right to Buy) $83.97 2027-07-31 Ordinary Shares (1191) Direct
Stock Option (Right to Buy) $89.08 2028-07-30 Ordinary Shares (22594) Direct
Stock Option (Right to Buy) $89.08 2028-07-30 Ordinary Shares (1695) Direct

Footnotes

F1: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.